Newsroom hero banner
split-image
first

Get the latest ZS news and press releases

We apply our knowledge, capabilities and innovation-oriented approach to a broad range of industries and client issues.
true
white
ABOUT ZS
false
Download the report
/content/dam/global/master/pdfs/esg-report-2024.pdf
primary
Second Button CTA Text
#
secondary
media-first
true
Sept 14, 2026
grey
ZS named a Leader in 2026 IDC MarketScape for Life Sciences R&D RWD/Real-World Evidence
h2
We believe this recognition reflects the impact clients experience firsthand.
true
/content/zs/en/insights/zs-leader-idc-marketscape-life-sciences-r-and-d-real-world-evidence-2026.html
Read the report
Read the report
primary
arrow-right
image
Join our team
asset
Paste your Ceros HTML code here (do not delete this text, add your code right after it):
Placeholder Logo Alt Text
This is placeholder text for the logo description. Please replace or remove this text when adding a logo.
default

ZS in the news

left
white
Eyebrow Text
Button CTA Text
#
primary
default
zs:content-type/press-release,zs:content-type/article,zs:content-type/podcast
https://hispanicexecutive.com/sandra-forero-zs/
Life at ZS
Hispanic Executive: Sandra Forero brings together culture, analytics and tech at ZS
2026-10-15T00:00:00.000Z
zs:content-type/article
https://partners.wsj.com/zs/innovating-healthcare/healing-patient-care-in-the-ai-age/
Healthcare
Wall Street Journal: Healing patient care in the AI age
2026-10-03T00:00:00.000Z
zs:content-type/article
https://www.pharmexec.com/view/your-product-is-ready-your-launch-strategy-isn-t
Pharmaceuticals & Biotech
PharmExec: our product is ready. Your launch strategy isn't
2026-08-11T00:00:00.000Z
zs:content-type/article
https://news.bloomberglaw.com/ip-law/tech-firms-welcome-federal-ai-regulatory-oversight-with-limits
AI & Analytics
Bloomberg: Tech firms welcome federal AI regulatory oversight, with limits
2026-07-27T00:00:00.000Z
zs:content-type/article
https://insights.citeline.com/in-vivo/innovation/china-leads-the-way-on-patient-trust-in-ai-AIX4DRHAAZACDP3EM5ZNWVMM4I/
AI & Analytics
In Vivo: China leads the way on patient trust in AI
2026-07-15T00:00:00.000Z
zs:content-type/article
https://hitconsultant.net/2026/06/26/zs-impact-institute-2026-future-of-health-report/
Healthcare
Hit Consultant: AI and the consumer-led care revolution
2026-06-26T00:00:00.000Z
zs:content-type/article
https://www.fiercehealthcare.com/ai-and-machine-learning/45-us-patients-wait-see-healthcare-providers-until-theyre-sick-zs-impact
Healthcare
Fierce Healthcare: AI playing a major role in consumers' healthcare decision-making
2026-06-30T00:00:00.000Z
zs:content-type/article
https://www.supplychainbrain.com/articles/44174-watch-the-future-of-ai-in-transportation-warehousing-and-logistics
Supply Chain & Manufacturing
Supply Chain Brain: The future of AI in transportation, warehousing and logistics
2026-06-29T00:00:00.000Z
zs:content-type/article
https://topconsultant.podbean.com/e/top-ai-consultant-zs-s-arun-shastri/
AI & Analytics
Top Consultant: Insights on AI, sales effectiveness and digital transformation
2026-06-10T00:00:00.000Z
zs:content-type/podcast
https://insights.citeline.com/scrip/conferences/jp-morgan/optimism-reigns-at-jp-morgan-despite-a-lack-of-deals-SKIPNRXU2VFSFFBDHFKIAT77VM/
Healthcare
Citeline: Optimism reigns at J.P. Morgan despite a lack of deals
2026-01-14T00:00:00.000Z
zs:content-type/article
https://www.forbes.com/sites/amyfeldman/2026/04/16/this-sam-altman-backed-18-billion-startup-bets-ai-can-get-drugs-through-clinical-trials-faster-formation-bio/
Pharmaceuticals & Biotech
Forbes: This startup bets AI can get drugs through clinical trials faster
2026-04-17T00:00:00.000Z
zs:content-type/article
https://www.pharmexec.com/view/the-pulse-of-pharma-change-in-2026
Pharmaceuticals & Biotech
PharmExec: The pulse of pharma change in 2026
2026-02-20T00:00:00.000Z
zs:content-type/podcast
https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2026-hold-for-biopharma-part-2-competitive-dynamics-a-landscape-reshaped-N4LP2AR3QVDJJBLQDPLYPVCZOI/
Pharmaceuticals & Biotech
Citeline: What does 2026 hold for biopharma?
2026-01-19T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/pharma-crystal-ball-2026-predictions-ai-drug-rd-development/809144/
Research & Development
PharmaVoice: What’s next for AI and drug R&D
2026-01-09T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/fda-drug-approval-takeda-novo-merck-lilly-2026/808924/
Pharmaceuticals & Biotech
PharmaVoice: 5 FDA drug approvals to watch in 2026
2026-01-07T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/dtc-advertisement-pharma-rfk-fda/760663/
Pharmaceuticals & Biotech
PharmaVoice: With DTC ads under fire, pharma companies need to pivot
2025-09-22T00:00:00.000Z
zs:content-type/article
https://www.hotelmanagement.net/data-trends/report-how-hoteliers-can-boost-profits-noncore-assets
Travel & Hospitality
Hotel Management: How hoteliers can boost profits with noncore assets
2025-09-16T00:00:00.000Z
zs:content-type/article
https://diginomica.com/wall-street-smells-blood-water-whats-ailing-consulting-and-research
Financial Services
Digimonica: As Wall Street smells blood in the water, what's ailing consulting and research?
2025-08-19T00:00:00.000Z
zs:content-type/article
Your patient's smartwatch could be a legal timebomb: are you liable?
2025-07-30T00:00:00.000Z
zs:content-type/article
https://medcitynews.com/2025/07/pharmaceutical-tariffs-supply-chain-drug-manufacturing-trade-wto-trump-cell-therapy-nkarta/
Supply Chain & Manufacturing
Med City News: The Myth of All-American Drugs and What Trump’s Tariffs Miss
2025-07-23T00:00:00.000Z
zs:content-type/article
https://www.pharmavoice.com/news/covid-vax-restrictions-market-uptake-hhs-rfk-moderna/750211/
Pharmaceuticals & Biotech
PharmaVoice: COVID vax restrictions may not hamper uptake — but market is still under pressure
2025-06-10T00:00:00.000Z
zs:content-type/article
https://www.pharmexec.com/view/the-three-pillars-of-pharma-s-new-commercial-model
Pharmaceuticals & Biotech
PharmaExec: The Three Pillars of Pharma’s New Commercial Model
2025-05-12T00:00:00.000Z
zs:content-type/article
https://www.techtarget.com/healthtechanalytics/feature/The-cost-of-AI-in-healthcare-explained-Is-it-worth-it
AI & Analytics
TechTarget: The cost of AI in healthcare explained. Is it worth it?
2025-05-01T00:00:00.000Z
zs:content-type/article
https://subscriber.politicopro.com/article/2026/01/health-care-leaders-call-for-moratorium-on-state-ai-laws-00733421?site=pro&prod=alert&prodname=alertmail&linktype=article&source=email
Healthcare
Politico: Healthcare leaders call for moratorium on state AI laws
2026-01-16T00:00:00.000Z
zs:content-type/article
https://www.fiercehealthcare.com/ai-and-machine-learning/hlc-proposes-path-ai-regulation-simple-strenuous
Healthcare
Fierce Healthcare: HLC proposes path to AI regulation, from simple to strenuous
2026-01-15T00:00:00.000Z
zs:content-type/article
https://www.pharmexec.com/view/scaling-ai-s-promise-in-healthcare-the-time-is-now
Healthcare
PharmExec: Scaling AI’s promise in healthcare: The time is now
2026-04-03T00:00:00.000Z
zs:content-type/podcast
https://www.precisionmedicineonline.com/regulatory-news-fda-approvals/can-rare-disease-drugmakers-trust-fdas-promises-flexibility-amid
Pharmaceuticals & Biotech
GenomeWeb: Can rare disease drugmakers trust FDA's promises of flexibility?
2026-03-02T00:00:00.000Z
zs:content-type/article
https://www.politico.com/news/2026/02/05/trumprx-debuts-here-is-what-you-need-to-know-00768440
Pharmaceuticals & Biotech
Politico: TrumpRx debuts with several dozen discounted drugs
2026-02-05T00:00:00.000Z
zs:content-type/article
https://themodernhotelier.com/episode/245
Travel & Hospitality
The Modern Hotelier: How hotels can leverage assets and technology in 2026
2026-01-27T00:00:00.000Z
zs:content-type/podcast
https://www.reuters.com/world/europe/european-health-chief-says-eu-must-flex-regional-muscle-ensure-drug-access-2026-04-22/
Pharmaceuticals & Biotech
Reuters: European health chief says EU is at 'a critical point' in ensuring new drug access
2026-04-22T00:00:00.000Z
zs:content-type/article
default

Press releases

left
white
Eyebrow Text
Button CTA Text
#
primary
default
/content/zs/en/about/newsroom
zs:content-type/press-release
https://www.aircanada.com/media/introducing-air-canada-embarq-a-new-self-serve-business-travel-platform-for-canadian-small-and-medium-sized-enterprises/
Travel & Hospitality
Air Canada Embarq, a new self-serve travel platform for small and medium-sized enterprises
2026-10-09T00:00:00.000Z
zs:content-type/press-release
https://www.businesswire.com/news/home/20260115349983/en/Healthcare-Sector-Calls-for-Unified-Federal-Framework-to-Unlock-AIs-Full-Potential-for-Patients
Healthcare
Healthcare sector calls for united Federal framework to unlock AI’s full potential
2026-01-15T00:00:00.000Z
zs:content-type/press-release
https://www.sapiosciences.com/news/sapio-sciences-zs-partnership-biopharma-lab-digitalization/
Life sciences
Sapio Sciences and ZS partner to advance lab digitalization in biopharma R&D and CMC
2026-06-02T00:00:00.000Z
zs:content-type/press-release
default

Company Announcements

left
white
Eyebrow Text
Button CTA Text
#
primary
default
image
6
Enhanced Card Title
h3
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Learn more
#
link
Enhanced Card Title
h3
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Learn more
#
link
ZS launches ZS Patient Core for emerging and midtier biopharma patient services
h3
Oct. 23, 2026
Read more
/content/zs/en/about/newsroom/zs-launches-patient-core-for-biopharma-patient-services
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS launches mid-cap pharma vertical to help companies accelerate growth and maximize portfolio value
h3
Oct. 20, 2026
Read more
/content/zs/en/about/newsroom/zs-launches-mid-cap-pharma-industry-vertical
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS showcases enterprise-scale AI execution at Dreamforce 2026
h3
Sept. 9, 2026
Read more
/content/zs/en/about/newsroom/zs-dreamforce-2026-salesforce-partnership
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS launches the ZS Impact Institute to help leaders navigate industry disruption
h3
June 24, 2026
Read more
/content/zs/en/about/newsroom/press-release-zs-impact-institute-launch
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS and Databricks advance clinical data speed and reliability across R&D
h3
June 16, 2026
Read more
/content/zs/en/about/newsroom/zs-and-databricks-clinical-data-hub-for-r-and-d
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS wins Databricks C&SI Life Sciences Partner of the Year for second year
h3
June 16, 2026
Read more
/content/zs/en/about/newsroom/zs-databricks-life-sciences-award-2026
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
ZS earns Microsoft Digital and App Innovation Solution Area recognition
h3
May 12, 2026
Read more
/content/zs/en/about/newsroom/microsoft-solutions-partner-digital-and-app-innovation-zs
link
default

Media contact

For more information, please contact our media relations team.

Contact
Maryam Ayromlou
Ruder Finn
zs-RFMedia@ruderfinn.com
+1 703 474 5685

left
true
grey
MEDIA RESOURCES
Button CTA Text
#
primary
default
image
ZS’s recognition and rankings
h3
Leading, independent industry experts have recognized ZS’s talent and culture.
Learn more
/content/zs/en/about/awards-and-recognition
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.
Fact sheet
h3
Get our corporate overview, executive bios and other important information about ZS.
Learn more
/content/dam/global/master/pdfs/factsheet-october-2026.pdf
link
Thank you for requesting a download of the Release Notes. A representative will contact you within 48 hours. If you have any questions, please contact us.